On 5 February 2026, France submitted additional information enabling a reassessment of the epidemiological situation in its territory. That information demonstrates a significant overall improvement, supported by a favourable risk assessment regarding the spread of lumpy skin disease virus, the effective implementation of the measures laid down in Delegated Regulation (EU) 2020/687, and the achievement of the minimum vaccination coverage required in accordance with Annex IX to Delegated Regulation (EU) 2023/361. In this context, the restricted zones established in the western part of the departments of Hautes-Pyrénées, Gers and Pyrénées-Atlantiques, as listed in Annex I to Implementing Decision (EU) 2025/1708, should be reassessed with a view to a partial lifting of the restrictions applied therein.
Recital 5, Decision_act (EU) 2026/393
In forcesince 17 Feb 2026